Full text
PDFPage 763
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Danahy D. T., Tobis J. M., Aronow W. S., Chetty K., Glauser F. Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):541–548. doi: 10.1002/cpt1979255part1541. [DOI] [PubMed] [Google Scholar]
- Keller C. A., Shepard J. W., Jr, Chun D. S., Dolan G. F., Vasquez P., Minh V. D. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis. 1984 Oct;130(4):606–611. doi: 10.1164/arrd.1984.130.4.606. [DOI] [PubMed] [Google Scholar]
- Kennedy T. P., Michael J. R., Huang C. K., Kallman C. H., Zahka K., Schlott W., Summer W. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Am Rev Respir Dis. 1984 Apr;129(4):544–551. [PubMed] [Google Scholar]
- MacNee W., Wathen C. G., Hannan W. J., Flenley D. C., Muir A. L. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1169–1172. doi: 10.1136/bmj.287.6400.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morrison D. A. Pulmonary hypertension in chronic obstructive pulmonary disease: the right ventricular hypothesis. Chest. 1987 Sep;92(3):387–389. doi: 10.1378/chest.92.3.387. [DOI] [PubMed] [Google Scholar]
- Muramoto A., Caldwell J., Albert R. K., Lakshminarayan S., Butler J. Nifedipine dilates the pulmonary vasculature without producing symptomatic systemic hypotension in upright resting and exercising patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985 Nov;132(5):963–966. doi: 10.1164/arrd.1985.132.5.963. [DOI] [PubMed] [Google Scholar]
- Oliver R. M., Peacock A. J., Fleming J. S., Waller D. G. Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease. Thorax. 1989 Jun;44(6):513–515. doi: 10.1136/thx.44.6.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peacock A., Busst C., Dawkins K., Denison D. M. Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1178–1180. doi: 10.1136/bmj.287.6400.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weitzenblum E., Hirth C., Ducolone A., Mirhom R., Rasaholinjanahary J., Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981 Oct;36(10):752–758. doi: 10.1136/thx.36.10.752. [DOI] [PMC free article] [PubMed] [Google Scholar]